Evaluation of absorption and depletion of florfenicol in European seabass Dicentrarchus labrax

Vet Med Sci. 2021 May;7(3):987-997. doi: 10.1002/vms3.415. Epub 2020 Dec 23.

Abstract

The pharmacokinetic properties and residue elimination of florfenicol (FLO) and its amine were investigated in European seabass Dicentrarchus labrax at 24°C. The trial mainly included analysis of FLO in plasma after a single dose dietary administration of 10 mg/kg and in muscle plus skin following a multiple dosing (10 mg kg-1 day-1 for 7 days) to estimate pharmacokinetics and residue depletion, respectively. The maximum plasma concentration of FLO was measured to be 1.64 μg/ml, 4 hr post administration. The elimination half-life (t1/2b ) and the area under the concentration-time curve extrapolated to infinity (AUC0-∞ ) were calculated to be 13.0 hr and 34.7 μg h-1 ml-1 , respectively. Withdrawal times of FLO and its amine were calculated to be 46.3 degree-days, indicating a fast removal from the edible tissues of treated European seabass. Overall, FLO can be considered as a potentially efficient antibacterial agent for farmed European seabass provided that additional efforts will be devoted towards its in vitro and clinical efficacy.

Keywords: florfenicol; florfenicol amine; muscle plus skin; pharmacokinetics; withdrawal time.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacokinetics*
  • Bass / metabolism*
  • Bioaccumulation
  • Thiamphenicol / analogs & derivatives*
  • Thiamphenicol / pharmacokinetics

Substances

  • Anti-Bacterial Agents
  • florfenicol
  • Thiamphenicol